Trade Bayer ^BAYGn

Teva-Sanofi upbeat on ‘best-in-class’ duvakitug bowel disease data | BioWorld

Bayer's high-dose eye treatment aflibercept shows positive late-stage trial results By Investing.com

Bayer Consumer Health champions green transportation - Chinadaily.com.cn

Kyorin in-licenses Bayer’s phase II sleep apnea drug for €85M+ | BioWorld

KYORIN Strikes Deal with Bayer for OSA Treatment | Markets Insider

BridgeBio Pharma Inc (BBIO) Receives Positive CHMP Opinion for Acoramidis in EU

Bayer Gets EU Backing for Heart Drug, Easing Patent Concerns

BridgeBio Pharma Announces CHMP's Positive Recommendation Of Acoramidis - Quick Facts

Bayer Bets on Barcelona with a New R&D Area in Health

Other news to note for Dec. 12, 2024 | BioWorld

Red mud generation trend across major countries, 2018 to 2023 | SMM

Moberg Pharma reports topline data in the North American phase 3 study and will regain rights to MOB-015 in EU | Morningstar

HEALTHCARE: Bayer (BAYNGR: Baa2 neg / BBB / BBB): Antonou Roundup mistrial

'Vague' Product Testing Allegations Sink Benzene Class Action

Pragmatic trade policies & focus on quality essential to create innovative drugs ecosystem in India: Experts

FDA Accepts Cytokinetics' Application for Cardiovascular Drug - December 3, 2024 - Zacks.com

OneMedNet Announces Exciting New Collaboration with Bayer's AI Innovation Platform to Help Accelerate Healthcare AI Development | The Manila Times

OneMedNet and Bayer team up for AI medical imaging By Investing.com

Lack of protective gear exposing farmers to chemicals - Beyer

Lack of protective gear exposing farmers to chemicals - Bayer

Another Option for Weed Control

Calls for Canada to ban bee-killing pesticides after damning CNO investigation | Canada's National Observer: Climate News

CREDIT SUPPLY: Heimstaden Bostad (HEIBOS: BB neg/BB neg): New Perp FV 6.70%

Dhanuka in pact with Bayer to acquire two active ingredients - The Hindu BusinessLine

BridgeBio's SWOT analysis: genetic disease fighter's stock faces pivotal moment By Investing.com

Dhanuka Agritech to acquire Bayer's crop protection products | Capital Market News - Business Standard

Non-exudative OCT findings in neovascular AMD

HER2-related biomarkers predict clinical outcomes with trastuzumab deruxtecan treatment in patients with HER2-expressing metastatic colorectal cancer: biomarker analyses of DESTINY-CRC01

Dhanuka Agritech jumps on inking pact with Bayer AG to acquire crop protection active ingredients

Dhanuka Agritech acquires two key ingredients from Bayer AG to expand global footprint

5 Stocks With the Largest Fair Value Estimate Cuts After Q3 Earnings | Morningstar

FDA Accepts Bayer's Application for Label Expansion of Nubeqa - November 22, 2024 - Zacks.com

Bayer gains exclusive licence for heart drug in Japan

U.S. FDA Accepts Supplemental New Drug Application for NUBEQA® (darolutamide) for the Treatment of Patients with Metastatic Hormone-Sensitive Prostate Cancer | Morningstar

UBS Reaffirms Their Hold Rating on Bayer (0P6S)

Pilot and feasibility studies in ophthalmology: fundamental keys to success

Mindsprint keen to focus on food and agriculture sectors, says its CEO - The Hindu BusinessLine

Pivot Bio Names Jason Hoag Head of North American Commercial Distribution | Morningstar

Cytokinetics, Bayer ink pact to develop HCM investigational drug Aficamten in Japan, ETPharma

Bayer Acquires Rights for Cardiovascular Drug From CYTK in Japan - November 20, 2024 - Zacks.com

Bayer recalls Yaz Plus contraceptives due to a quality issue | SAnews

Bayer AG shares target cut to EUR25 from EUR29 by CFRA By Investing.com

Goldman Sachs maintains Neutral on Cytokinetics, $60 target By Investing.com

Cytokinetics Will Get More Revenue for Marketing Aficamten in Japan

How Bayer, Evonik & Henkel can Reduce Supply Chain Emissions

Cytokinetics and Bayer Announce Exclusive Licensing Collaboration for Aficamten in Japan | The Manila Times

Bayer acquires rights to Cytokinetics' heart drug in Japan By Reuters

Tesla stock hits new high: Why is TSLA stock is up today?

What is the FTSE 100: FTSE 100 analysis for European investors

Nikkei 225 performance today: Beginner’s guide to Japan’s stock market

MicroStrategy Stock Price: MSTR stock saw an increase of 0.15% today

Gold price today: gold holds two-day decline ahead of Fed rate cut

Latest cryptocurrency news: What is bitcoin, Ethereum explained

Broadcom stock price soars 23% as AI revenues spike 220%

Morning Note: Tesla Hits Record High Amid US PMI Focus and Bitcoin's Next Move